Correlations of MicroRNA-487a-3p and A Kinase-Interacting Protein 1 mRNA Levels in Endometrial Cancer Tissue With Patient Survival Within Five Years After Surgery

Dandan ZHAO, Su’e ZHANG, Liye MIAO, Yan WANG

Acta Academiae Medicinae Sinicae ›› 2025, Vol. 47 ›› Issue (5) : 792-800.

PDF(1039 KB)
Home Journals Acta Academiae Medicinae Sinicae
Acta Academiae Medicinae Sinicae

Abbreviation (ISO4): Acta Academiae Medicinae Sinicae      Editor in chief: Xuetao CAO

About  /  Aim & scope  /  Editorial board  /  Indexed  /  Contact  / 
PDF(1039 KB)
Acta Academiae Medicinae Sinicae ›› 2025, Vol. 47 ›› Issue (5) : 792-800. DOI: 10.3881/j.issn.1000-503X.16319
Original article

Correlations of MicroRNA-487a-3p and A Kinase-Interacting Protein 1 mRNA Levels in Endometrial Cancer Tissue With Patient Survival Within Five Years After Surgery

Author information +
History +

Abstract

Objective To investigate the relationships of the expression of microRNA-487a-3p (miR-487a-3p) and A kinase-interacting protein 1 (AKIP1) mRNA in the endometrial cancer (EC) tissue with the patient survival within 5 years after surgery. Methods The EC tissue and adjacent normal tissue samples were collected from 130 EC patients who underwent surgical treatment at the Fourth Hospital of Shijiazhuang from September 2016 to April 2019.qRT-PCR was employed to determine the expression levels of miR-487a-3p and AKIP1 mRNA.The patients were followed up for 5 years after surgery to record the survival status.After removal of the patients who missed follow-up,78 surviving patients were recorded as the EC survival group,and 34 deceased patients were recorded as the EC death group.The dual luciferase reporter gene assay was conducted to verify the targeting relationship between miR-487a-3p and AKIP1 mRNA.Comparison was conducted for the expression levels of miR-487a-3p and AKIP1 mRNA between adjacent normal tissue and EC tissue,the expression levels of miR-487a-3p and AKIP1 mRNA in the EC tissue among patients with different clinical pathological parameters,and the clinical pathological parameters and the expression levels of miR-487a-3p and AKIP1 mRNA in the EC tissue between the EC survival group and the EC death group.The correlations of miR-487a-3p and AKIP1 mRNA levels in the EC tissue with the degree of tumor differentiation,International Federation of Gynecology and Obstetrics (FIGO) stage,lymph node metastasis,and depth of muscle invasion were analyzed.The relationships of miR-487a-3p and AKIP1 mRNA with patient prognosis and the risk factors affecting the survival of EC patients within 5 years after surgery were analyzed to evaluate the value of miR-487a-3p and AKIP1 mRNA levels in predicting the survival of EC patients within 5 years after survival. Results The EC tissue showed lower miR-487a-3p level (0.41±0.08 vs. 1.00±0.05;t=71.306,P<0.001) and higher AKIP1 mRNA level (2.35±0.37 vs. 1.00±0.03;t=41.465,P<0.001) than the adjacent normal tissue.The miR-487a-3p low expression group and AKIP1 mRNA high expression group had higher proportions of patients with low tumor differentiation,FIGO stage Ⅲ to Ⅳ,lymph node metastasis,and deep invasion of muscle layer than the miR-487a-3p high expression group and AKIP1 mRNA low expression group,respectively (all P<0.05).The results of dual luciferase reporter gene assay showed that the relative activity of luciferase in the miR-487a-3p small interfering RNA (siRNA)+AKIP1 mRNA-wild type (WT) group was higher than that in the miR-487a-3p empty vector+AKIP1 mRNA-WT group (2.85±0.19 vs. 1.00±0.04;t=23.339,P<0.001).There was no significant difference in the relative activity of luciferase between the miR-487a-3p empty vector+AKIP1 mRNA-mutant type (MUT) group and the miR-487a-3p siRNA+AKIP1 mRNA-MUT group (1.04±0.05 vs. 1.05±0.03;t=0.420,P=0.683).MiR-487a-3p in the EC tissue had negative correlations with AKIP1 mRNA,FIGO stage,lymph node metastasis,and depth of muscle invasion and a positive correlation with the degree of tumor differentiation (all P<0.001).AKIP1 mRNA had positive correlations with FIGO stage,lymph node metastasis,and depth of muscle invasion and a negative correlation with the degree of tumor differentiation (all P<0.001).The 5-year overall survival rates in the miR-487a-3p high expression group and AKIP1 mRNA low expression group (89.47% and 84.91%) were higher than those in the miR-487a-3p low expression group and AKIP1 mRNA high expression group (49.09% and 55.93%),respectively (both P<0.05).The EC death group had higher proportions of patients with low tumor differentiation,FIGO stage Ⅲ to Ⅳ,lymph node metastasis,and deep invasion of muscle layer,higher AKIP1 mRNA level in the EC tissue,and lower miR-487a-3p level than the EC survival group (all P<0.05).Low tumor differentiation,FIGO stage Ⅲ to Ⅳ,lymph node metastasis,deep invasion of muscle layer,low miR-487a-3p level,and high AKIP1 mRNA level were independent risk factors for the survival of EC patients within 5 years after surgery (all P<0.05).The area under curve (AUC) values of miR-487a-3p and AKIP1 mRNA alone (0.785 and 0.789,respectively) were lower than that of their combination (0.908) in predicting the survival of EC patients within 5 years after surgery (both P<0.05). Conclusion The EC tissue has a low miR-487a-3p level and a high AKIP1 mRNA level,both of which are correlated with clinicopathological parameters and prognosis and can be used to predict the survival of EC patients within 5 years after surgery.

Key words

endometrial cancer / microRNA-487a-3p / A kinase-interacting protein 1 / survival within 5 years after surgery

Cite this article

Download Citations
Dandan ZHAO , Su’e ZHANG , Liye MIAO , et al. Correlations of MicroRNA-487a-3p and A Kinase-Interacting Protein 1 mRNA Levels in Endometrial Cancer Tissue With Patient Survival Within Five Years After Surgery[J]. Acta Academiae Medicinae Sinicae. 2025, 47(5): 792-800 https://doi.org/10.3881/j.issn.1000-503X.16319

References

[1]
Gaffney D, Matias-Guiu X, Mutch D, et al. 2023 FIGO staging system for endometrial cancer:the evolution of the revolution[J]. Gynecol Oncol, 2024, 184(1):245-253.DOI:10.1016/j.ygyno.2024.02.002.
[2]
Jamieson A, McAlpine JN. Molecular profiling of endometrial cancer from TCGA to clinical practice[J]. J Natl Compr Canc Netw, 2023, 21(2):210-216.DOI:10.6004/jnccn.2022.7096.
[3]
Shazly SA, Coronado PJ, Yılmaz E, et al. Endometrial cancer individualized scoring system (ECISS):a machine learning-based prediction model of endometrial cancer prognosis[J]. Int J Gynaecol Obstet, 2023, 161(3):760-768.DOI:10.1002/ijgo.14639.
[4]
Iavarone I, Molitierno R, Fumiento P, et al. MicroRNA expression in endometrial cancer:current knowledge and therapeutic implications[J]. Medicina (Kaunas), 2024, 60(3):486-498.DOI:10.3390/medicina60030486.
[5]
Ye Z, Jiang Y, Wu J. A novel necroptosis-associated miRNA signature predicting prognosis of endometrial cancer and correlated with immune infiltration[J]. Taiwan J Obstet Gynecol, 2023, 62(2):291-298.DOI:10.1016/j.tjog.2022.09.009.
[6]
Yu L, Ren Y. Long noncoding RNA small nucleolar RNA host gene 3 mediates prostate cancer migration,invasion,and epithelial-mesenchymal transition by sponging miR-487a-3p to regulate TRIM25[J]. Cancer Biother Radiopharm, 2022, 37(6):451-465.DOI:10.1089/cbr.2020.3988.
[7]
Zhang X, Liu S, Zhu Y. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer[J]. Cell Biochem Funct, 2020, 38(6):782-791.DOI:10.1002/cbf.3547.
[8]
中国抗癌协会妇科肿瘤专业委员会. 子宫内膜癌诊断与治疗指南(第四版)[J]. 中国实用妇科与产科杂志, 2018, 34(8):880-886.DOI:10.19538/j.fk2018080114.
[9]
Wang Y, Wang B, Ma X. A novel predictive model based on inflammatory response-related genes for predicting endometrial cancer prognosis and its experimental validation[J]. Aging (Albany NY), 2023, 15(11):4844-4860.DOI:10.18632/aging.204767.
[10]
Gorzelnik K, Wasaznik-Jedras A, Wicherek L, et al. Expression of B7-H4 in endometrial cancer and its impact on patients’ prognosis[J]. Ginekol Pol, 2024, 95(4):252-258.DOI:10.5603/gpl.96605.
[11]
Zhu Y, Tang Y, Fan Y, et al. MiR-196a-5p facilitates progression of estrogen-dependent endometrial cancer by regulating FOXO1[J]. Histol Histopathol, 2023, 38(10):1157-1168.DOI:10.14670/HH-18-572.
[12]
Blagojević S, Andrić B, Jovankić J, et al. MicroRNA expression as a diagnostic parameter in early endometrial cancer[J]. Int J Gynecol Cancer, 2023, 33(9):1394-1401.DOI:10.1136/ijgc-2023-004579.
[13]
Mosaad H, Abdelrahman AE, Abdullatif A, et al. MIR-379-5p expression in endometrial cancer and its correlation with ROR1 expression[J]. Asian Pac J Cancer Prev, 2023, 24(1):239-248.DOI:10.31557/APJCP.2023.24.1.239.
[14]
Lee KJ, Singh N, Bizuneh M, et al. MiR-429 suppresses endometrial cancer progression and drug resistance via DDX53[J]. J Pers Med, 2023, 13(9):1302-1316.DOI:10.3390/jpm13091302.
[15]
Sun Y, Cao Z, Shan J, et al. Hsa_circ_0020095 promotes oncogenesis and cisplatin resistance in colon cancer by sponging miR-487a-3p and modulating SOX9[J]. Front Cell Dev Biol, 2021, 8:604869.DOI:10.3389/fcell.2020.604869.
[16]
Wang L, Ge S, Zhou F. MicroRNA-487a-3p inhibits the growth and invasiveness of oral squamous cell carcinoma by targeting PPM1A[J]. Bioengineered, 2021, 12(1):937-947.DOI:10.1080/21655979.2021.1884396.
[17]
Wan S, Liu C, Li C, et al. AKIP1 accelerates glioblastoma progression through stabilizing EGFR expression[J]. Oncogene, 2023, 42(39):2905-2918.DOI:10.1038/s41388-023-02796-2.
[18]
Xue S, Zhang C, Xu J, et al. Prognostic significance of A-kinase interacting protein 1 expression in various cancers:a meta-analysis based on the Chinese population[J]. Medicine (Baltimore), 2022, 101(25):e29203.DOI:10.1097/MD.0000000000029203.
[19]
Ahmed MM, Lateef MA, Elwan A, et al. Prognostic value of immunohistochemical expression of MTAP and AKIP1 in IDH1 mutant astrocytoma[J]. Asian Pac J Cancer Prev, 2023, 24(11):3875-3882.DOI:10.31557/APJCP.2023.24.11.3875.
[20]
Lin R, Zhao S, Su L, et al. A kinase-interacting protein 1 may serve as a potential biomarker for deteriorative tumor features and poor prognosis in gastric cancer patients[J]. J Clin Lab Anal, 2020, 34(8):e23350.DOI:10.1002/jcla.23350.
PDF(1039 KB)

Accesses

Citation

Detail

Sections
Recommended

/